€500k - €1.2mFirst value signal
Registered business in FR. Official registry identity, filed financial evidence and a public indicative value curve on one indexed company profile.
Historical indicative ranges based on public filings. This is not an asking price or confirmation that the company is for sale.
Based on filed company accountsThe historical curve shows where this company stood. Unlock what holds back value today, what it could be in five years and which actions matter now.
Free account · private workspace
Public filings are a starting point. Accounts, owner context and method review narrow the range and make it useful for a sale, financing or transfer.
Own this company? Claim and manage the profileYou have seen the historical curve. Create a free account to explore a private five-year value scenario and the assumptions behind it.
The valuation for EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT combines official public company figures with Upswitch sector calibration. The owner can sharpen it with their own figures and context into a full, defensible valuation curve.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Operating as a business in NACE sector 72.11, EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT is registered in France. The company was founded in 2012, incorporated as a 5710.
EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT is listed in French National Business Register (RNE/INPI) under registry number 790219174. The public employee band is 21, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Within the French NACE 72.11 cluster, public-record data is filed annually via the national company registry.
A public indicative value curve is available for EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT, based on filed company accounts. A free account unlocks the five-year outlook and concrete actions to increase value.
The most recent annual filing covers 2024 (period end 2024-12-31).
This page is refreshed whenever new regulator-filed data for EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT becomes available, consolidated into a single audit-grade view.
Public regulator-filed figures across 8 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202431 Dec 2024 | - | - | €2,171,564 | €448,977 | - |
| 202331 Dec 2023 | €0 | - | €2,256,019 | €480,687 | - |
| 202231 Dec 2022 | €6,639 | - | €2,553,033 | €461,581 | - |
| 202131 Dec 2021 | - | - | €2,067,828 | €173,558 |
EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT was founded in 2012 and is registered with French National Business Register (RNE/INPI), incorporated as a 5710.
EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT is registered under NACE 72.11: NACE 72.11. That places the business within the French cluster for this activity.
This page shows a rounded, automated indicative range generated by Upswitch from official registry facts, public company-size information, filed accounts where available, and governed sector benchmarks. The evidence basis is labelled beside the graph. It is not a certified or statutory valuation, sale price, offer, recommendation, or financial, investment, tax or legal advice. Figures for EUROFINS PHARMA PRODUCTS TESTING FRANCE MANAGEMENT may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
| - |
| 202031 Dec 2020 | - | - | €2,309,320 | €330,806 | - |
| 201931 Dec 2019 | - | - | €1,705,232 | €287,617 | - |
| 201831 Dec 2018 | - | - | €1,162,319 | €229,461 | - |
| 201731 Dec 2017 | - | - | €1,125,399 | €277,601 | - |
The most recently filed annual accounts cover fiscal year 2024 (period end 2024-12-31), publicly available via French National Business Register (RNE/INPI).
